Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPO-202 for central abdominal bulging
NCT02397499Phase 3Completed
- Sponsor
- Neothetics
- Start
- Apr 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salmeterol in subcutaneous fat, sponsored by Neothetics. Started Apr 2015; status: completed.
02
Drugs
salmeterol
03
Conditions
subcutaneous fat
Beyond the preview
Go deeper on NCT02397499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02397499.